The U.S. Centers for Medicare and Medicaid Services (CMS) said on Wednesday that it would seek “greater transparency” in drug price negotiations under President Donald Trump’s administration. The statement follows criticism from the pharmaceutical industry regarding the program.
Read more...
Hence then, the article about the trump administration promises greater transparency in drug price negotiations was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Trump administration promises 'greater transparency' in drug price negotiations )
Also on site :
- Der Quark Electric Drive von GAC erhält als weltweit erster Antrieb die doppelte Zertifizierung nach DAkkS ASIL D für funktionale Sicherheit und Informationssicherheit
- Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company
- Hyun Woo Kim, President and CEO of the Seoul Business Agency: "The Global Innovation Forum, bringing together startup ecosystem leaders from seven countries, will mark a milestone in innovation and growth through startup exchange"